Neuromusculoskeletal Interface for Bionic Arms

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorShirley Ryan AbilityLab

About this trial

The overall objective of this proposal is to perform a first-in-human home trial of the Electronic Osseoanchored Prostheses for the Rehabilitation of Amputees (e-OPRA) implant system in individuals with transhumeral amputations who have had Targeted Muscle Reinnervation (TMR) surgery and use a pattern recognition-controlled myoelectric prosthesis. The purpose of the study is to capture preliminary safety and effectiveness information on the e-OPRA device when used with the prosthetic systems. The investigators expect that the e-OPRA implant system will be safe and provide clinically and statistically significant improvements in control and comfort.

Specifically, the investigators hypothesize that the e-OPRA system will (1) allow for training of more functional prosthesis controllers, (2) provide more stable electromyographic (EMG) signals, reducing the need to recalibrate the prosthetic control system, and (3) be more comfortable, as it does not require a tethered arm-band to record surface EMG signals.

Phase 1: Perform TMR and e-OPRA surgeries in 8 persons with transhumeral amputations.

Phase 2: Perform a randomized cross-over study to compare the OPRA and e-OPRA system (without sensory feedback) in 8 transhumeral amputees who have received TMR.

Phase 3: Perform a randomized cross-over study to compare the e-OPRA system with and without sensory feedback in 8 transhumeral amputees who have received TMR.

Eligibility criteria

Qualifiers

Between the ages of 18 and 70 years old

Unilateral transhumeral level absence

Candidate for a myoelectric prosthesis (can generate mV level electromyographic EMG signals as detected by surface electrodes).

Candidate for TMR surgery as verified by surgical team

Disqualifiers

Significant new injury that would prevent use of a prosthesis: The ability to consistently wear a prosthesis and perform activities of daily living and specific performance tasks is necessary to evaluate the relative benefits of the interventions.

Cognitive impairment sufficient to adversely affect understanding of, or compliance with, study requirements, ability to communicate experiences, or ability to give informed consent: The ability to understand and comply with requirements of the study is essential in order for the study to generate usable, reliable data. The ability to obtain relevant user feedback through questionnaires and informal discussion adds significant value to this study. These cognitive impairments would be confirmed with the Mini-Mental State exam.

Proximal nerve injury that would prevent TMR or sensory feedback

Significant other comorbidity: Any other medical issues or injuries that would preclude completion of the study, use of the prostheses, or that would otherwise prevent acquisition of useable data by researchers. Examples include: injuries to the shoulder, cervical spine or sound side joint pain that would prohibit the participants from being able use a prosthesis. Medical conditions including unregulated high blood pressure or advanced heart disease that would exclude the participant as an appropriate surgical candidate.

Trial design

Treatments tested in this trial

  • eOPRA
  • OPRA
  • eOPRA with sensory feedback
  • eOPRA without sensory feedback

Treatment groups

12 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Shirley Ryan AbilityLab

Lead sponsor

Integrum

Collaborator

Northwestern Memorial Hospital

Collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator